All Cancer articles
-
NewsMacmillan analysis reveals rise in late cancer diagnoses in England
Analysis carried out by Macmillan Cancer Support reveals the impact of COVID-19 on patients waiting to receive cancer treatment
-
PHE/DH/DWP guideline
PHE caries, gum disease, and oral cancer prevention guidance
A short summary of guidance to equip community pharmacy teams with advice for patients of all ages on caries, periodontal disease, and oral cancer prevention
-
News
Clinical history of hypothyroidism linked to endometrial cancer survival outcomes
A study has found an association between clinical history of hypothyroidism and endometrial cancer survival outcomes
-
News
UK Lung Cancer Coalition: pandemic has had a devastating impact on lung cancer outcomes
A new report from the UKLCC estimates that delays in diagnosis caused by COVID-19 lockdowns may result in a drop of up to 5.3% in 5-year survival in England
-
News
Breakthrough in predicting risks of late effects in paediatric cancer
University College London study links paediatric cancer with increased illness later in life
-
News
New treatment for thyroid cancer available through Cancer Drugs Fund
NICE has published guidance recommending selpercatinib on the Cancer Drugs Fund for thyroid cancer
-
NICE guideline
NICE suspected cancer in primary care guideline
A summary of guidance to assist GPs on the recognition and referral of suspected cancer
-
News
CBD oil linked to lung cancer tumour regression
Research is warranted on the potential use of cannabidiol oil as a primary treatment for cancer, say the authors of a new case report published by the BMJ
-
Independent professional body guideline
RPS cancer support guideline
A summary of initiatives that utilise the skill mix of community pharmacy teams to support people with cancer within the community
-
News
Scotland launches cancer care strategy for children and young people
The Scottish Government has introduced a 5-year strategy for delivering top-class cancer care for children and young people
-
News
Cancer ‘public’s top health concern’
As the COVID-19 pandemic comes under control, cancer is re-emerging as Britain’s leading health priority
-
News
GP 2-week wait cancer referrals double over 10 years
GP referrals through the 2-week wait cancer diagnosis pathway have doubled over 10 years, leading to a 68% increase in the number of cancers detected, according to a new study
-
News
Nivolumab to be routinely available on the NHS for head and neck carcinoma
The NICE draft guidance appraisal committee concluded that nivolumab meets the criteria to be considered a cost-effective, life-extending treatment at the end of life
-
News
New trial of blood test to detect cancer before symptoms begin
The trial of the test, which can detect more than 50 types of cancer before symptoms appear, will be conducted in eight areas of England
-
News
NHS England urges public to be cancer symptom-aware as new campaign launches
NHS England Chief Executive Amanda Pritchard has said that the NHS is ‘open and ready’ for anyone displaying potential cancer symptoms, and urges the public to recognise the signs
-
News
NICE recommends abemaciclib for advanced breast cancer
New draft guidance from NICE recommends twice-daily abemaciclib with fulvestrant for adults with hormone receptor-positive, HER2-negative breast cancer
-
News
Cancer-related cognitive impairment in men with prostate cancer
Study findings suggest patients’ subjective concerns of cancer-related cognitive impairment appear to be critical to patient outcomes
-
News
COVID-19 rapid guideline on haematopoietic stem cell transplantation updated by NICE
The updated guidance recommends the use of PCR testing before conditioning therapy, and a repeat respiratory review following COVID-19 infection
-
On demand webinars
Half-day virtual event focusing on practical approaches to management of gastrointestinal disorders and iron deficiency
Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines.
UK-COR-NP-2100043
Date of preparation: July 2021 -
News
New drug that halves cancer recurrence risk to be offered by NHS
NHS England is to roll out a new drug which halves the risk of cancer for patients dealing with a return of the disease after undergoing treatment
